BioSpace News Archive

AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal diseases, today announced that it has entered into an agreement with Creapharm Clinical Supplies (“Creapharm”), a leader in clinical trial supply services, for the packaging, labelling and distribution of Phase 2 clinical trial drug product supply of its MS1819 therapy for the treat

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, reported financial results for the first quarter ended March 31, 2020, and provided a business update.

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced its financial results for the first quarter ended March 31, 2020.

Company maintains strong balance sheet with $223.2 million in cash, cash equivalents and short-term investments

BIOLASE, Inc., the global leader in dental lasers, announced its financial results for the first quarter ended March 31, 2020.

Cutera, Inc., a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, reported financial results for the first quarter ended March 31, 2020.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced financial results for the three months ended March 31, 2020.

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company focused on novel and targeted oncology therapies, announced financial results for the three-month period ended March 31, 2020.

Expected initiation of three new short-term zuranolone clinical studies in 2020, with the potential for three distinct indications

Dicerna Pharmaceuticals, Inc., a leading developer of investigational ribonucleic acid interference therapeutics, announced that Douglas Pagán will become Dicerna’s chief financial officer and a member of the Company’s executive leadership team, effective May 26, 2020.